DrugDashboards

Tofacitinib

Tofacitinib · TOFACITINIB CITRATE 11 mg/1 · Tablet, Extended Release · Oral · Ajanta Pharma USA Inc.

NDC 27241-0270-30 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Sep 2026Sep 2026$2.19
1 price point · per EASource: CMS NADAC

Estimated fill cost

#30 count
$65.78
#90 count
$197.34

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 4 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for tofacitinib (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA219542
TE code
AB
Approval date
Aug 19, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Tofacitinib (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Ajanta Pharma USA Inc.TOFACITINIB CITRATE 11 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedTOFACITINIB CITRATE 11 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.TOFACITINIB CITRATE 11 mg/1Aug 12, 2026Sep 2, 2026
U.S. PharmaceuticalsTOFACITINIB CITRATE 11 mg/1Jul 15, 2026Sep 2, 2026
U.S. PharmaceuticalsTOFACITINIB CITRATE 22 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tofacitinib — NDC 27241-0270-30," retrieved September 3, 2026, https://drugdashboards.com/drug/27241027030.

Free to cite with attribution — see how the data is put together.